Skip to main content

The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.

Publication ,  Journal Article
Barkley, A; Butler, E; Park, C; Friedman, A; Landi, D; Ashley, DM; Bigner, D; Bernstock, JD; Friedman, GK; Johnston, JM; Thompson, EM
Published in: J Neurosurg Pediatr
April 1, 2024

OBJECTIVE: Relatively little is known about the safety and accuracy of catheter placement for oncolytic viral therapy in children with malignant brain tumors. Accordingly, this study combines data from two phase I clinical trials that employed viral immunotherapy across two institutions to describe the adverse event profile, safety, and accuracy associated with the stereotactic placement and subsequent removal of intratumoral catheters. METHODS: Children with progressive/recurrent supratentorial malignant tumors were enrolled in two clinical trials (NCT03043391 and NCT02457845) and treated with either the recombinant polio:rhinovirus (lerapolturev) or the genetically modified oncolytic herpesvirus (G207). Age, sex, race, tumor diagnosis, and tumor location were analyzed. Events related to the catheter placement or removal were categorized. A catheter that was either pulled back or could not be used was defined as "misplaced." Neuronavigation software was used to analyze the accuracy of catheter placement for NCT03043391. Descriptive statistics were performed. RESULTS: Nineteen patients were treated across the two completed trials with a total of 49 catheters. The mean ± SD (range) age was 14.1 ± 3.6 (7-19) years. All tumors were grade 3 or 4 gliomas. Nonlobar catheter tip placement included the corpus callosum, thalamus, insula, and cingulate gyrus. Six of 19 patients (31.6%) had minor hemorrhage noted on CT; however, no patients were symptomatic and/or required intervention related to these findings. One of 19 patients had a delayed CSF leak after catheter removal that required oversewing of the surgical site. No patients developed infection or a neurological deficit. In 7 patients with accuracy data, the mean ± SD distance of the planned trajectory (PT) to the catheter tip was 1.57 ± 1.6 mm, the mean angle of the PT to the catheter was 2.43° ± 2.1°, and the greatest distance of PT to the catheter in the parallel plane was 1.54 ± 1.5 mm. Three of 49 (6.1%) catheters were considered misplaced. CONCLUSIONS: Although instances of minor hemorrhage were encountered, they were clinically asymptomatic. One of 49 catheters required intervention for a CSF leak. Congruent with previous studies in the literature, the stereotactic placement of catheters in these pediatric tumor patients was accurate with approximately 95% of catheters having been adequately placed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Neurosurg Pediatr

DOI

EISSN

1933-0715

Publication Date

April 1, 2024

Volume

33

Issue

4

Start / End Page

359 / 366

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Neoplasm Recurrence, Local
  • Immunotherapy
  • Humans
  • Hemorrhage
  • Child
  • Catheters
  • Brain Neoplasms
  • Adolescent
  • 3213 Paediatrics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barkley, A., Butler, E., Park, C., Friedman, A., Landi, D., Ashley, D. M., … Thompson, E. M. (2024). The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study. J Neurosurg Pediatr, 33(4), 359–366. https://doi.org/10.3171/2023.12.PEDS23404
Barkley, Ariana, Eric Butler, Christine Park, Allan Friedman, Daniel Landi, David M. Ashley, Darell Bigner, et al. “The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.J Neurosurg Pediatr 33, no. 4 (April 1, 2024): 359–66. https://doi.org/10.3171/2023.12.PEDS23404.
Barkley A, Butler E, Park C, Friedman A, Landi D, Ashley DM, et al. The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study. J Neurosurg Pediatr. 2024 Apr 1;33(4):359–66.
Barkley, Ariana, et al. “The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.J Neurosurg Pediatr, vol. 33, no. 4, Apr. 2024, pp. 359–66. Pubmed, doi:10.3171/2023.12.PEDS23404.
Barkley A, Butler E, Park C, Friedman A, Landi D, Ashley DM, Bigner D, Bernstock JD, Friedman GK, Johnston JM, Thompson EM. The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study. J Neurosurg Pediatr. 2024 Apr 1;33(4):359–366.

Published In

J Neurosurg Pediatr

DOI

EISSN

1933-0715

Publication Date

April 1, 2024

Volume

33

Issue

4

Start / End Page

359 / 366

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Neoplasm Recurrence, Local
  • Immunotherapy
  • Humans
  • Hemorrhage
  • Child
  • Catheters
  • Brain Neoplasms
  • Adolescent
  • 3213 Paediatrics